CommentaryPublished 30 Sep 2024
Bladder Cancer Prognosis and Treatment: The Impact of Genetic Markers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, U.S.A
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Bladder cancer remains one of the most common malignancies globally, with significant variability in patient outcomes. Recent advancements in genetic research have highlighted the pivotal role of genetic markers in enhancing our understanding of bladder cancer prognosis and guiding treatment decisions. This paper explores the impact of genetic markers on the diagnosis, progression, and management of bladder cancer. Genetic mutations, such as those involving the FGFR3, TP53, and RB1 genes, are increasingly recognized for their potential to predict disease outcomes, response to therapy, and risk of recurrence. By identifying specific genetic alterations, clinicians can adopt a more personalized approach to treatment, selecting targeted therapies and immunotherapies tailored to an individual’s molecular profile. Additionally, genetic markers provide valuable insights into the tumor’s aggressiveness, aiding in risk stratification and treatment optimization. The integration of genetic testing into routine clinical practice has the potential to revolutionize bladder cancer management, improving survival rates and quality of life for patients. As research continues to unravel the complexities of the genetic landscape of bladder cancer, the utilization of genetic markers will become a cornerstone of precision medicine in this field. This review discusses current findings, challenges, and the future implications of genetic markers in the prognosis and treatment of bladder cancer.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAdvances in Cancer Prevention
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Ely Virtuosic”